Literature DB >> 7026871

Pyelonephritis: the relationship between infection, renal scarring, and antimicrobial therapy.

T Miller, S Phillips.   

Abstract

We studied the relationship between infection, renal scarring, and antimicrobial therapy in pyelonephritis by an experimental model of the disease. Our specific concern was to identify those aspects of the acute phase of infection associated with the induction of the inflammatory response. Our hypothesis was that the degree of the inflammatory response and the extent of the subsequent lesion in the kidney depended on the rate at which a critical number of microorganisms was reached in the kidney. We proposed that the rapid increase in bacterial numbers in the kidney was the stimulus initiating the inflammatory response and not the total number of microorganisms in the kidney. In the experimental investigation, we treated animals with induced renal infection at varying intervals after the establishment of infection, and we determined the effect of antimicrobial therapy on the bacteriologic, gross, and histopathologic features of the disease. The early events relating to the bacterial invasion of the kidney were important determinants but the hypothesis needed extending to account for the fact that antimicrobial agents, administered after bacterial numbers had reached a plateau, still reduced markedly the damage to the kidney. Two factors seem to be involved in the genesis of the pyelonephritic lesion. The first is the rate of acquisition of a bacterial population by a previously sterile organ, but an additional and important component is the total number of microorganisms in the kidney up to 4 days after challenge. Clinically, the results are relevant in that they demonstrate that renal scarring can be prevented or significantly reduced by prompt antimicrobial therapy.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7026871     DOI: 10.1038/ki.1981.65

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  27 in total

1.  Cellular basis of host defence in pyelonephritis. I. Chronic infection.

Authors:  T E Miller; G Findon; S Cawley
Journal:  Br J Exp Pathol       Date:  1986-02

2.  Cellular basis of host defence in pyelonephritis. II. Acute infection.

Authors:  T E Miller; G Findon; S Cawley; I Clarke
Journal:  Br J Exp Pathol       Date:  1986-04

3.  Cytokine profiles of pediatric patients treated with antibiotics for pyelonephritis: potential therapeutic impact.

Authors:  K Kassir; O Vargas-Shiraishi; F Zaldivar; M Berman; J Singh; A Arrieta
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

4.  Tubulointerstitial inflammation, cast formation, and renal parenchymal damage in experimental pyelonephritis.

Authors:  B Iványi; J Ormos; J Lantos
Journal:  Am J Pathol       Date:  1983-12       Impact factor: 4.307

5.  Scarring as a factor affecting the eradication of microorganisms from the kidney in pyelonephritis.

Authors:  T Miller
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

6.  Retrospective study of children with renal scarring associated with reflux and urinary infection.

Authors:  J M Smellie; A Poulton; N P Prescod
Journal:  BMJ       Date:  1994-05-07

7.  TLR-4 polymorphisms and leukocyte TLR-4 expression in febrile UTI and renal scarring.

Authors:  Meral Torun Bayram; Alper Soylu; Halil Ateş; Sefa Kızıldağ; Salih Kavukçu
Journal:  Pediatr Nephrol       Date:  2013-04-24       Impact factor: 3.714

8.  Influence of inflammation on the efficacy of antibiotic treatment of experimental pyelonephritis.

Authors:  P R Meylan; G Braoudakis; M P Glauser
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

9.  L-651,392, a potent leukotriene inhibitor, controls inflammatory process in Escherichia coli pyelonephritis.

Authors:  M Tardif; D Beauchamp; Y Bergeron; C Lessard; P Gourde; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

10.  Age as a main determinant of renal functional damage in urinary tract infection.

Authors:  U B Berg; S B Johansson
Journal:  Arch Dis Child       Date:  1983-12       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.